XAGEW

Longevity Health Holdings, Inc. (XAGEW)

$0.01

Last Close (24-hour delay)

PASS

• BUY Advisory
• SELL Advisory (Profit)​
• SELL Advisory (Loss)​

• Profit
• Loss
• Pass (Skip investing)

Stock price based on last close

*as per simulation
(see disclosures)

Upturn Star Rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock

Historic Profit 0%

Avg. Invested days 0

Today’s Advisory PASS

Upturn Star Rating

Upturn Advisory Performance 1.0

Stock Returns Performance 1.0

Profits based on simulation

Last Close 10/14/2025

Upturn AI SWOT

Longevity Health Holdings, Inc.

Company Overview

History and Background

It appears Longevity Health Holdings, Inc. is a privately held company and not publicly traded. Because of this, there is limited information and the request cannot be fulfilled. No financial data is available.

Core Business Areas

Leadership and Structure

No information available.

Top Products and Market Share

Key Offerings

Market Dynamics

Industry Overview

No information available.

Positioning

No information available.

Total Addressable Market (TAM)

No information available.

Upturn SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

Competitors and Market Share

Key Competitors

Competitive Landscape

No information available.

Growth Trajectory and Initiatives

Historical Growth: No information available.

Future Projections: No information available.

Recent Initiatives: No information available.

Summary

Longevity Health Holdings, Inc. is a privately held company, therefore very limited information is available. It is difficult to determine the company's strength or weakness, what is working well, and what it needs to look out for.

Peer Comparison

Sources and Disclaimers

Data Sources:

• Publicly available search engines.
• Company websites (if available).

Disclaimers:

The information provided is based on limited publicly available data. The analysis is constrained by the lack of verifiable financial statements and comprehensive company details. This analysis should not be considered financial advice.

AI Summarization is directionally correct and might not be accurate.

Summarized information shown could be a few years old and not current.

Fundamental Rating based on AI could be based on old data.

AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

Longevity Health Holdings, Inc., a bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products. The company utilizes Carmell Secretome and Elevai Exosomes to support skin and hair health. Its Carmell Secretome consists of growth factors, proteins, and peptides extracted from allogeneic human platelets; and Elevai Exosomes constains growth factors, cytokines, peptides, and other small molecules involved in the body's natural healing process. The company also develops a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products. It has licensing agreement with Carnegie Mellon University to develop and commercialize biocompatible plasma-based plastics. The company was formerly known as Carmell Corporation and changed its name to Longevity Health Holdings, Inc. in March 2025. Longevity Health Holdings, Inc. was founded in 2008 and is headquartered in Pittsburgh, Pennsylvania.